AnaptysBio
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $108,249 | $76,320 | $22,263 | $27,771 |
Gross Profit | 216,237 | 44,913 | -15,561 | -13,409 |
EBITDA | 67,506 | 38,238 | -18,384 | -20,618 |
EBIT | 66,900 | 37,628 | -18,985 | -21,224 |
Net Income | 49,614 | 15,113 | -38,630 | -39,329 |
Net Change In Cash | 108,249 | 76,320 | 22,263 | 27,771 |
Free Cash Flow | 97,996 | -27,368 | -40,283 | -10,735 |
Cash | 238,196 | 109,833 | 44,298 | 98,637 |
Basic Shares | 31,343 | 29,018 | 28,810 | 30,644 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $234,603 | $91,280 | $17,157 | $10,287 |
Gross Profit | 232,180 | -72,560 | -115,126 | -78,511 |
EBITDA | 50,319 | -92,744 | -156,420 | -105,257 |
EBIT | 47,896 | -95,141 | -157,072 | -107,592 |
Net Income | -13,232 | -145,231 | -163,619 | -128,723 |
Net Change In Cash | 234,603 | 91,280 | 17,157 | 10,287 |
Cost of Revenue | -424,421 | |||
Free Cash Flow | 19,610 | -135,695 | -121,607 | -73,951 |
Cash | 238,196 | 123,080 | 35,965 | 71,308 |
Basic Shares | 31,343 | 28,382 | 26,924 | 28,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $1.58 |
2025-09-30 | $0.52 |
2025-06-30 | -$1.34 |
